Santhik Subhasingh Lupitha
Overview
Explore the profile of Santhik Subhasingh Lupitha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiwari S, Chandrasekharan A, Lupitha S, Mathew K, Jancy S, Halikar A, et al.
Free Radic Biol Med
. 2025 Feb;
230:190-208.
PMID: 39947492
Tumor hypoxia determines tumor growth, metastasis, drug resistance, and tumor heterogeneity through multiple mechanisms, largely dependent on the extent of hypoxia, further modulated by re-oxygenation events. In order to track...
2.
Jancy S, Lupitha S, Chandrasekharan A, Varadarajan S, Nelson-Sathi S, Prasad R, et al.
Biol Proced Online
. 2023 Jul;
25(1):22.
PMID: 37495994
Background: The entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the host cell is mediated through the binding of the SARS-CoV-2 Spike protein via the receptor binding domain...
3.
Lupitha S, Darvin P, Chandrasekharan A, Varadarajan S, Divakaran S, Easwaran S, et al.
Antib Ther
. 2022 Apr;
5(2):100-110.
PMID: 35437514
Quantitative determination of neutralizing antibodies against Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) is paramount in immunodiagnostics, vaccine efficacy testing, and immune response profiling among the vaccinated population. Cost-effective, rapid,...
4.
Varadarajan S, Mathew K, Chandrasekharan A, Lupitha S, Lekshmi A, Mini M, et al.
J Cell Biochem
. 2022 Feb;
123(4):782-797.
PMID: 35106828
Cancer cells grown as 3D-structures are better models for mimicking in vivo conditions than the 2D-culture systems employable in drug discovery applications. Cell cycle and cell death are important determinants...
5.
Lupitha S, Chandrasekhar L, Varadarajan S, Jayaprasad A, Chandrasekharan A, Patil S, et al.
Toxicol Lett
. 2020 Feb;
326:23-30.
PMID: 32109534
Simultaneous detection of autophagy and apoptosis is important in drug discovery and signaling studies. Here we report, a real-time reporter cell line for the simultaneous detection of apoptosis and autophagy...
6.
Chandrasekharan A, Varadarajan S, Lekshmi A, Lupitha S, Darvin P, Chandrasekhar L, et al.
Redox Biol
. 2018 Nov;
20:379-389.
PMID: 30408753
Most toxic compounds including cancer drugs target mitochondria culminating in its permeabilization. Cancer drug-screening and toxicological testing of compounds require cost-effective and sensitive high-throughput methods to detect mitochondrial damage. Real-time...
7.
Lekshmi A, Varadarajan S, Lupitha S, Nair M, Chandrasekharan A, Santhoshkumar T
Curr Protoc Toxicol
. 2018 Mar;
75:2.27.1-2.27.16.
PMID: 29512126
Recent cell biology studies reveal that a cell can die through multiple pathways via distinct signaling mechanisms. Among these, apoptosis and necrosis are two distinct cell death pathways, and their...
8.
Indira D, Varadarajan S, Lupitha S, Lekshmi A, Mathew K, Chandrasekharan A, et al.
Eur J Cell Biol
. 2017 Nov;
97(1):1-14.
PMID: 29092745
The selective autophagic removal of mitochondria called mitophagy is an essential physiological signaling for clearing damaged mitochondria and thus maintains the functional integrity of mitochondria and cells. Defective mitophagy is...
9.
Lekshmi A, Varadarajan S, Lupitha S, Indira D, Mathew K, Chandrasekharan Nair A, et al.
Cell Death Discov
. 2017 Feb;
3:16101.
PMID: 28179996
Apoptosis and necrosis are the two major forms of cell death mechanisms. Both forms of cell death are involved in several physiological and pathological conditions and also in the elimination...